Iqvia stock drops after FDA questions sales data

Iqvia's stock dropped nearly 8 percent Wednesday after the U.S. Food and Drug Administration issued a statement questioning sales data from the company.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2018 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news